210 related articles for article (PubMed ID: 14641068)
1. Glycation in food and metabolic transit of dietary AGEs (advanced glycation end-products): studies on the urinary excretion of pyrraline.
Foerster A; Henle T
Biochem Soc Trans; 2003 Dec; 31(Pt 6):1383-5. PubMed ID: 14641068
[TBL] [Abstract][Full Text] [Related]
2. Determination of urinary pyrraline by solid-phase extraction and high performance liquid chromatography.
Yoshihara K; Kiyonami R; Shimizu Y; Beppu M
Biol Pharm Bull; 2001 Aug; 24(8):863-6. PubMed ID: 11510474
[TBL] [Abstract][Full Text] [Related]
3. Evidence against the formation of 2-amino-6-(2-formyl-5-hydroxymethyl-pyrrol-1-yl)-hexanoic acid ('pyrraline') as an early-stage product or advanced glycation end product in non-enzymic protein glycation.
Smith PR; Somani HH; Thornalley PJ; Benn J; Sonksen PH
Clin Sci (Lond); 1993 Jan; 84(1):87-93. PubMed ID: 8382140
[TBL] [Abstract][Full Text] [Related]
4. Urinary pyrraline as a biochemical marker of non-oxidative Maillard reactions in vivo.
Portero-Otín M; Pamplona R; Bellmunt MJ; Bergua M; Nagaraj RH; Prat J
Life Sci; 1997; 60(4-5):279-87. PubMed ID: 9010483
[TBL] [Abstract][Full Text] [Related]
5. Studies on absorption and elimination of dietary maillard reaction products.
Förster A; Kühne Y; Henle T
Ann N Y Acad Sci; 2005 Jun; 1043():474-81. PubMed ID: 16037269
[TBL] [Abstract][Full Text] [Related]
6. Glycaemic control and in vivo non-oxidative Maillard reaction: urinary excretion of pyrraline in diabetes patients.
Portero-Otín M; Pamplona R; Bellmunt MJ; Bergua M; Prat J
Eur J Clin Invest; 1997 Sep; 27(9):767-73. PubMed ID: 9352249
[TBL] [Abstract][Full Text] [Related]
7. Chromatographic evidence for pyrraline formation during protein glycation in vitro and in vivo.
Portero-Otin M; Nagaraj RH; Monnier VM
Biochim Biophys Acta; 1995 Feb; 1247(1):74-80. PubMed ID: 7873594
[TBL] [Abstract][Full Text] [Related]
8. Determination of Free-Form and Peptide Bound Pyrraline in the Commercial Drinks Enriched with Different Protein Hydrolysates.
Liang Z; Li L; Qi H; Zhang X; Xu Z; Li B
Int J Mol Sci; 2016 Jul; 17(7):. PubMed ID: 27384561
[TBL] [Abstract][Full Text] [Related]
9. Quantitation of free glycation compounds in saliva.
Manig F; Hellwig M; Pietz F; Henle T
PLoS One; 2019; 14(9):e0220208. PubMed ID: 31532774
[TBL] [Abstract][Full Text] [Related]
10. Formation and elimination of pyrraline in the Maillard reaction in a saccharide-lysine model system.
Liang Z; Li L; Fu Q; Zhang X; Xu Z; Li B
J Sci Food Agric; 2016 May; 96(7):2555-64. PubMed ID: 26260362
[TBL] [Abstract][Full Text] [Related]
11. Ovalbumin modified with pyrraline, a Maillard reaction product, shows enhanced T-cell immunogenicity.
Heilmann M; Wellner A; Gadermaier G; Ilchmann A; Briza P; Krause M; Nagai R; Burgdorf S; Scheurer S; Vieths S; Henle T; Toda M
J Biol Chem; 2014 Mar; 289(11):7919-28. PubMed ID: 24505139
[TBL] [Abstract][Full Text] [Related]
12. Pyrraline Formation Modulated by Sodium Chloride and Controlled by Encapsulation with Different Coating Materials in the Maillard Reaction.
Liang Z; Chen X; Yang Z; Lai Y; Yang Y; Lei C; Zeng Y
Biomolecules; 2019 Nov; 9(11):. PubMed ID: 31717655
[TBL] [Abstract][Full Text] [Related]
13. Detection of Free Advanced Glycation End Products in Vivo during Hemodialysis.
Hohmann C; Liehr K; Henning C; Fiedler R; Girndt M; Gebert M; Hulko M; Storr M; Glomb MA
J Agric Food Chem; 2017 Feb; 65(4):930-937. PubMed ID: 28112514
[TBL] [Abstract][Full Text] [Related]
14. Transport of the advanced glycation end products alanylpyrraline and pyrralylalanine by the human proton-coupled peptide transporter hPEPT1.
Geissler S; Hellwig M; Zwarg M; Markwardt F; Henle T; Brandsch M
J Agric Food Chem; 2010 Feb; 58(4):2543-7. PubMed ID: 20104847
[TBL] [Abstract][Full Text] [Related]
15. First evidence for accumulation of protein-bound and protein-free pyrraline in human uremic plasma by mass spectrometry.
Odani H; Shinzato T; Matsumoto Y; Takai I; Nakai S; Miwa M; Iwayama N; Amano I; Maeda K
Biochem Biophys Res Commun; 1996 Jul; 224(1):237-41. PubMed ID: 8694819
[TBL] [Abstract][Full Text] [Related]
16. Formation of Peptide Bound Pyrraline in the Maillard Model Systems with Different Lys-Containing Dipeptides and Tripeptides.
Liang Z; Li L; Qi H; Wan L; Cai P; Xu Z; Li B
Molecules; 2016 Apr; 21(4):463. PubMed ID: 27070556
[TBL] [Abstract][Full Text] [Related]
17. High levels of urinary pentosidine, an advanced glycation end product, in children with acute exacerbation of atopic dermatitis: relationship with oxidative stress.
Tsukahara H; Shibata R; Ohta N; Sato S; Hiraoka M; Ito S; Noiri E; Mayumi M
Metabolism; 2003 Dec; 52(12):1601-5. PubMed ID: 14669163
[TBL] [Abstract][Full Text] [Related]
18. Pyrraline ether crosslinks as a basis for protein crosslinking by the advanced Maillard reaction in aging and diabetes.
Nagaraj RH; Portero-Otin M; Monnier VM
Arch Biochem Biophys; 1996 Jan; 325(2):152-8. PubMed ID: 8561492
[TBL] [Abstract][Full Text] [Related]
19. Dietary intake of advanced glycation endproducts is associated with higher levels of advanced glycation endproducts in plasma and urine: The CODAM study.
Scheijen JLJM; Hanssen NMJ; van Greevenbroek MM; Van der Kallen CJ; Feskens EJM; Stehouwer CDA; Schalkwijk CG
Clin Nutr; 2018 Jun; 37(3):919-925. PubMed ID: 29381139
[TBL] [Abstract][Full Text] [Related]
20. Increased urinary levels of pentosidine, pyrraline and acrolein adduct in type 2 diabetes.
Daimon M; Sugiyama K; Kameda W; Saitoh T; Oizumi T; Hirata A; Yamaguchi H; Ohnuma H; Igarashi M; Kato T
Endocr J; 2003 Feb; 50(1):61-7. PubMed ID: 12733710
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]